Integrity Applications has developed a non-invasive glucose monitor. The device utilizes a patented combination of ultrasonic, electromagnetic, and thermal technologies which measure three distinct criteria to provide a glucose measurement
GlucoTrack enables type 2 diabetic patients and pre-diabetic patients to measure their glucose levels without drawing blood. A small sensor clips comfortably to the ear lobe while glucose level is calculated using a proprietary algorithm and displayed on hand held device the size of a smart phone.
GlucoTrack removes the two most significant barriers to frequent monitoring of glucose levels by diabetics: pain (the device is non-invasive) and cost (no disposables are required).
GlucoTrack Model DF-F is intended for use in non-invasive quantitative spot measurement of glucose, for home-use.
The GlucoTrack Model DF-F is intended for use by adults (over the age of 18 years old) type 2 diabetic patients, as well as pre-diabetic patients. Medications intake/treatment decisions should not be based only on measurements by GlucoTrack model DF-F. The GlucoTrack Model DF-F is a monitoring device and should not be used for diagnosis.
Integrity Applications’ GlucoTrack model DF-F has been proven for safety and performances for patients in clinical studies conducted by third party, under the supervision of leading diabetes authorities at the Soroka University Medical Center in Israel. The upgraded device has gained a CE-Mark approval in December 2015.